嘉亨家化(300955.SZ):擬向全資子公司湖州嘉亨增資1.6億元
格隆匯9月23日丨嘉亨家化(300955.SZ)公佈,公司於2022年9月23日召開第二屆董事會第六次會議,審議通過了《關於使用自有資金向全資子公司增資的議案》.
為進一步滿足全資子公司湖州嘉亨實業有限公司(簡稱“湖州嘉亨”)的經營發展需要,根據公司的發展戰略並結合實際情況,公司擬使用自有資金1.6億元向湖州嘉亨進行增資,其中增加註冊資本1億元,其餘6000萬元計入湖州嘉亨的資本公積,增資完成後,湖州嘉亨的註冊資本由2億元增加到3億元,公司仍持有其100%股權。
湖州嘉亨成立於2017年12月5日,法定代表人曾煥彬,註冊資本2億元,經營範圍包括化粧品生產;消毒劑生產(不含危險化學品);衞生用品和一次性使用醫療用品生產;包裝裝潢印刷品印刷;第二類醫療器械生產等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.